Catalent, Inc. and Novo Holdings A/S have fulfilled all regulatory closing conditions for their pending transaction, expected to close in the coming days. Catalent's CEO, Alessandro Maselli, expressed excitement for the company's future under Novo Holdings' ownership, emphasizing innovation and enhanced offerings. Jonathan Levy, Senior Partner at Novo Holdings, highlighted the benefits of the transaction for driving healthcare innovation and improving patient outcomes.